Clinical trial
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage…
NCT00003930 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003930 |
|---|---|
| Title | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer |
| Official title | A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, gemcitabine hydrochloride, paclitaxel, conventional surgery, radiation therapy |
| Enrollment | 84 |
| Start date | Sep 1, 1999 |
| Primary completion | Jul 1, 2003 |
| Completion | Nov 1, 2013 |
| First posted | Sep 30, 2003 |
| Last update posted | Oct 20, 2020 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: